Mortier, L., Meyer, N., Grob, J., Pouriel, M., Carpentier, D. d., & Saïag, P. The RoMEO study: A real-world, observational, prospective investigation of dabrafenib and trametinib combination treatment in patients with BRAF V600 unresectable or metastatic cutaneous melanoma. Elsevier.
Chicago Style (17th ed.) CitationMortier, L., N. Meyer, J.-J Grob, M. Pouriel, D. de Carpentier, and P. Saïag. The RoMEO Study: A Real-world, Observational, Prospective Investigation of Dabrafenib and Trametinib Combination Treatment in Patients with BRAF V600 Unresectable or Metastatic Cutaneous Melanoma. Elsevier.
MLA (9th ed.) CitationMortier, L., et al. The RoMEO Study: A Real-world, Observational, Prospective Investigation of Dabrafenib and Trametinib Combination Treatment in Patients with BRAF V600 Unresectable or Metastatic Cutaneous Melanoma. Elsevier.